MET and neoplasm: A further activator of the AKT/mTOR pathway in PMe is speculated to be the hepatocyte growth factor receptor (c‐Met), the dysregulation of which contributes to the regulation of cell growth, motility, and invasion, as well as confers tumours the ability to metastasize [82].